chitosan has been researched along with Cardiometabolic Syndrome in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (12.50) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
Authors | Studies |
---|---|
Tao, W; Wang, G; Wei, J | 1 |
Al-Okbi, SY; Ali, O; Aly, AS; Elbakry, HFH; Esmail, RSH; Refaat, D | 1 |
Guo, W; Li, M; Yi, L; Zhou, B | 1 |
Cao, X; Feng, B; Li, X; Yan, C; Zhang, C | 1 |
Chiang, MT; Chiu, CY; Liu, SH; Shi, CM | 1 |
Bai, Y; Du, Y; Feng, C; Jiao, S; Liu, H; Yuan, X; Zheng, J; Zheng, L | 1 |
Belcaro, G; Cesarone, MR; Cornelli, M; Cornelli, U | 1 |
Akasaki, K; Anraku, M; Kondo, Y; Maezaki, Y; Maruyama, T; Michihara, A; Nishio, H; Otagiri, M; Tomida, H; Tsuchiya, D; Yasufuku, T | 1 |
3 review(s) available for chitosan and Cardiometabolic Syndrome
Article | Year |
---|---|
The Role of Chitosan Oligosaccharide in Metabolic Syndrome: A Review of Possible Mechanisms.
Topics: Anticholesteremic Agents; Aquatic Organisms; Chitosan; Humans; Insulin Resistance; Metabolic Syndrome; Obesity; Oligosaccharides | 2021 |
Chitosan modifies glycemic levels in people with metabolic syndrome and related disorders: meta-analysis with trial sequential analysis.
Topics: Blood Glucose; Chitosan; Glycated Hemoglobin; Humans; Insulin; Metabolic Syndrome | 2020 |
Intestinal Population in Host with Metabolic Syndrome during Administration of Chitosan and Its Derivatives.
Topics: Acetyl-CoA Carboxylase; AMP-Activated Protein Kinases; Animals; Chitosan; Cytokines; Fatty Acids; Gastrointestinal Microbiome; Humans; Hypolipidemic Agents; Inflammation; Intestines; Lipids; Metabolic Syndrome; Phosphorylation; Reactive Oxygen Species | 2020 |
1 trial(s) available for chitosan and Cardiometabolic Syndrome
Article | Year |
---|---|
Use of polyglucosamine and physical activity to reduce body weight and dyslipidemia in moderately overweight subjects.
Topics: Adult; Anticholesteremic Agents; Biomarkers; Blood Glucose; Body Mass Index; Body Weight; Chitosan; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Dyslipidemias; Female; Humans; Male; Metabolic Syndrome; Middle Aged; Motor Activity; Overweight; Treatment Outcome; Triglycerides; Waist Circumference; Weight Loss | 2008 |
4 other study(ies) available for chitosan and Cardiometabolic Syndrome
Article | Year |
---|---|
Management of metabolic syndrome by nutraceuticals prepared from chitosan and ferulic acid with or without beta-sitosterol and their nanoforms.
Topics: Animals; Atorvastatin; Chitosan; Diet, High-Fat; Dietary Supplements; Fructose; Insulin Resistance; Metabolic Syndrome; Rats | 2023 |
Functional Comparison of High and Low Molecular Weight Chitosan on Lipid Metabolism and Signals in High-Fat Diet-Fed Rats.
Topics: Animals; Anticholesteremic Agents; Blood Glucose; Chitosan; Diet, High-Fat; Dietary Supplements; Disease Models, Animal; Humans; Intestinal Absorption; Intestinal Mucosa; Intestines; Lipid Metabolism; Lipids; Lipogenesis; Liver; Male; Metabolic Syndrome; Molecular Weight; Oxidation-Reduction; Rats; Rats, Sprague-Dawley | 2018 |
Chitosan Oligosaccharides Improve Glucolipid Metabolism Disorder in Liver by Suppression of Obesity-Related Inflammation and Restoration of Peroxisome Proliferator-Activated Receptor Gamma (PPARĪ³).
Topics: Animals; Chitosan; Cytokines; Diet, High-Fat; Disease Models, Animal; Glycolipids; Hep G2 Cells; Humans; Inflammation Mediators; Lipid Metabolism; Liver; Male; Metabolic Syndrome; Mice; Mice, Inbred C57BL; Obesity; Oligosaccharides; PPAR gamma; Treatment Outcome; Up-Regulation | 2018 |
The antioxidative and antilipidemic effects of different molecular weight chitosans in metabolic syndrome model rats.
Topics: Albumins; Animals; Antioxidants; Blood Glucose; Body Weight; Chitosan; Cholesterol; Cholesterol, LDL; Creatinine; Dietary Supplements; Disease Models, Animal; Dose-Response Relationship, Drug; Free Radicals; Gastrointestinal Tract; Hypolipidemic Agents; Male; Metabolic Syndrome; Molecular Weight; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Reference Values; Triglycerides | 2010 |